Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Tuberculosis Diagnostics Market, by End Use
1.4.2 Europe Tuberculosis Diagnostics Market, by Type
1.4.3 Europe Tuberculosis Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Europe Tuberculosis Diagnostics Market by End Use
4.1 Europe Diagnostic Laboratories Market by Country
4.2 Europe Hospitals & Clinics Market by Country
4.3 Europe Others Market by Country
Chapter 5. Europe Tuberculosis Diagnostics Market by Type
5.1 Europe Detection of Latent Infection (Skin Test & IGRA) Market by Country
5.2 Europe Phage Assay Market by Country
5.3 Europe Detection of Drug Resistance (DST) Market by Country
5.4 Europe Nucleic Acid Testing Market by Country
5.5 Europe Radiographic Method Market by Country
5.6 Europe Cytokine Detection Assay Market by Country
5.7 Europe Diagnostic Laboratory Methods Market by Country
5.8 Europe Other Methods Market by Country
Chapter 6. Europe Tuberculosis Diagnostics Market by Country
6.1 Germany Tuberculosis Diagnostics Market
6.1.1 Germany Tuberculosis Diagnostics Market by End Use
6.1.2 Germany Tuberculosis Diagnostics Market by Type
6.2 UK Tuberculosis Diagnostics Market
6.2.1 UK Tuberculosis Diagnostics Market by End Use
6.2.2 UK Tuberculosis Diagnostics Market by Type
6.3 France Tuberculosis Diagnostics Market
6.3.1 France Tuberculosis Diagnostics Market by End Use
6.3.2 France Tuberculosis Diagnostics Market by Type
6.4 Russia Tuberculosis Diagnostics Market
6.4.1 Russia Tuberculosis Diagnostics Market by End Use
6.4.2 Russia Tuberculosis Diagnostics Market by Type
6.5 Spain Tuberculosis Diagnostics Market
6.5.1 Spain Tuberculosis Diagnostics Market by End Use
6.5.2 Spain Tuberculosis Diagnostics Market by Type
6.6 Italy Tuberculosis Diagnostics Market
6.6.1 Italy Tuberculosis Diagnostics Market by End Use
6.6.2 Italy Tuberculosis Diagnostics Market by Type
6.7 Rest of Europe Tuberculosis Diagnostics Market
6.7.1 Rest of Europe Tuberculosis Diagnostics Market by End Use
6.7.2 Rest of Europe Tuberculosis Diagnostics Market by Type
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Qiagen N.V.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Product Launches and Product Expansions:
7.2.6 SWOT Analysis
7.3 Thermo Fisher Scientific, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.3.6 SWOT Analysis
7.4 Becton, Dickinson, and Company
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.6 SWOT Analysis
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and Mergers:
7.5.6 SWOT Analysis
7.6 Hologic, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 SWOT Analysis
7.7 Danaher Corporation
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 SWOT Analysis
7.8 DiaSorin S.p.A.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expenses
7.8.5 SWOT Analysis
7.9 Bruker Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 SWOT Analysis
7.10. Revvity, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expenses
7.10.5 SWOT Analysis
Unique Offerings 